Bluesky · Hashtag

#GLP1

228
posts · 30d
113
users
8
posts / day
2.0
posts / user
+ 44% vs last week

#GLP1 is an active hashtag on Bluesky. In the last 30 days, 113 people shared 228 posts with it — around 8 a day. Activity is up 44% versus the previous week, peaking on Nov 3 with 14 posts.

#GLP1 posts per day (last 30 days)

Posts with #GLP1

“That sugar cookie with the DONK” 🌻🌻
@sadandyellow.bsky.social
2 days ago
Hot Pilates class; we were doing Bird Dogs and Teasers to the Ying Yang Twins. 💪🏼 (I love having a Black instructor!!) I’m wearing blue all week ya’ll!! #Blexas #BlackSkyFitness #FitnessSky #GLP1 #GLP-1 #WeightLifting #Pilates #Cardio
2 1 13
Stina Börchers, PhD
@stinaborchers.bsky.social
3 days ago
Can obesity drugs protect the brain? 🧠 In our new review in Science, we look at what we know, and what we don't, about GLP-1-based drugs like semaglutide and tirzepatide and cognition. Short answer: promising, but we are not there yet 🧵 🧪 #neuroskyence #glp1 #obesitydrugs
Obesity pharmacotherapies and cognition

www.science.org

Obesity pharmacotherapies and cognition

Pharmacotherapies for obesity and type 2 diabetes are increasingly being evaluated for their effects on cognition and brain health. Evidence from preclinical models, observational cohorts, and clinica...

5 8 17
Stephen Stone, MD 🔬🧬🐁✏️
@stevestonedraws.bsky.social
3 days ago
Randy J. Seeley, PhD (2026 Diabetes Research Day Keynote): the gut brain axis is the key metabolic regulator of body weight. Bile acid signaling and Reg3g gut barrier formation are necessary. Rebound weight gain is mechanism, not pharmacokinetics #Obesity #GLP1 #GIPR #Diabetes @seeleyrj.bsky.social
0 0 3
JAMA Psychiatry
@jamapsychiatry.com
3 days ago
Among adults with serious mental illness, #GLP1 receptor agonists vs #SGLT2 inhibitors were associated with lower mortality and fewer major cardiovascular events, with greater absolute benefit in serious mental illness. ja.ma/4iu5HUc
GLP-1 Receptor Agonists, Mortality, and CV Outcomes in Mental Illness

ja.ma

GLP-1 Receptor Agonists, Mortality, and CV Outcomes in Mental Illness

This study assesses the association of glucagon-like peptide-1 receptor agonists vs sodium-glucose cotransporter-2 inhibitors with all-cause mortality and major adverse cardiovascular events among adults with and without serious mental illness.

0 1 2
Canadian Journal of Physiology and Pharmacology
@physiolpharma.bsky.social
4 days ago
📣CJPP Incretins in Action collection Current clinical application of incretin therapy for obesity management | Skinner and Clements Read it here: ow.ly/WK9z5102FYC #GLP1 #OpenAccess
Image: Incretin molecular structure
Text: Canadian Journal of Physiology and Pharmacology. Incretins in Action: Unlocking New Frontiers from Bench to Bedside.
0 0 1

Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.